About NanoBrid
NanoBrid is a Healthcare company based in Pilani (India) founded in 2020 by Anupama Mittal, Mayank Bhanderi, Deepak Chitkara, and Nemisha Patel. It develops nanotechnology for efficient drug delivery and improved patient outcomes. It operates on a B2B model. The company has 1 employees. Its Indian entity Nanobrid Innovations Private Limited reported revenue of ₹30.5 Lakh. NanoBrid offers products and services including Nanobrid Platform. Its focus areas include Biotechnology, Nanotechnology and Drug Delivery.
Company details
Nanobrid specializes in a proprietary lipid-polymer hybrid nanotechnology platform that enhances drug delivery by addressing challenges like stability and efficacy. It enables the formulation and administration of difficult-to-deliver active ingredients across therapeutic areas, including topical, injectable, and oral routes. Based in India, the company focuses on superior drug entrapment and safety, targeting pharmaceutical applications to improve clinical outcomes and patient experiences.
- Headquarters Pilani, India
- Employees 1
- Founders Anupama Mittal, Mayank Bhanderi, Deepak Chitkara, Nemisha Patel
- SectorsHealthcare
- Website nano-brid.com
- Legal Name Nanobrid Innovations Private Limited
- Date of Incorporation 25 Jun, 2020
- Jurisdiction Punjab, India
- Annual Revenue₹30.5 Lakh
FY 2025 · +46% YoY
- Net Loss-₹30.4 Lakh
FY 2025 · -100% margin
- EBITDA-₹28.3 Lakh
FY 2025 · -93% margin
- Employee Count1
Associated legal entities of NanoBrid
NanoBrid operates through Nanobrid Innovations Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Nanobrid Innovations Private Limited CIN U74999PB2020PTC051227 | Active | 25 Jun 2020 | ₹0.3 Cr | 2 | View details |
Products & Services of NanoBrid
NanoBrid offers a comprehensive portfolio of products and services, including Nanobrid Platform.
Hybrid nanotechnology for stable drug release and therapeutic efficacy.
Board of directors of Nanobrid Innovations Private Limited (NanoBrid)
Nanobrid Innovations Private Limited is the primary company behind NanoBrid. The board of Nanobrid Innovations Private Limited currently have 2 directors; the longest-serving is Deepak Chitkara, appointed in 2020. 1 earlier director has ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Deepak Chitkara DIN 08772062 | Director | 25 Jun 2020 | 6 yrs 4 mo | Nanobrid Innovations Private Limited |
| Mayank Bhailalbhai Bhanderi DIN 08977828 | Director | 02 Dec 2020 | 5 yrs 11 mo | Nanobrid Innovations Private Limited |
People of NanoBrid
4 people are tracked at NanoBrid (4 in leadership); the tracked headcount is 1.
| Name | Role | Group |
|---|---|---|
| Co-Founder | Leadership | |
| Co-Founder | Leadership | |
| Co-Founder | Leadership | |
Nemisha Patel | Co-Founder | Leadership |
Complete people profiles for NanoBrid
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of NanoBrid
Figures of Nanobrid Innovations Private Limited, the primary company behind NanoBrid, for FY 2025. Revenue was ₹30.5 Lakh (+46% year on year). Net loss was -₹30.4 Lakh (-100% margin). EBITDA was -₹28.3 Lakh (-93% margin). Revenue has grown at a compounded annual rate of +103% over three years.
- ₹30.5 LakhRevenue · FY 2025 · +46% YoY
- -₹30.4 LakhNet loss · -100% margin
- -₹28.3 LakhEBITDA · -93% margin
- ₹7.6 LakhPaid-up capital
- +103%Revenue CAGR, 3 years
Balance sheet, profit and loss, cash flow and ratios of Nanobrid Innovations Private Limited are on its company page.
Detailed financial statements for NanoBrid
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Top companies in Biopharma Outsourcing & Drug Delivery
3 companies that operate in the same segment as NanoBrid (Biopharma Outsourcing & Drug Delivery) in India, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Developer of integrated contract research development and manufacturing services | 2007 | Bengaluru, Karnataka, India | USD 35.74 M | USD 226.38 M | 2,062 | |
Pharmaceutical and biotechnology company | 2005 | Hyderabad, Telangana, India | USD 229.73 M | USD 726.15 M | 548 | |
India's leading healthcare products distribution platform | 2018 | Mumbai, Maharashtra, India | USD 59.67 M | USD 702.49 M | 557 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about NanoBrid
NanoBrid was founded in 2020.
NanoBrid is headquartered in Pilani, India. It is registered at Pilani, Rajasthan, India.
NanoBrid has 1 employees.
The primary company behind NanoBrid, Nanobrid Innovations Private Limited, reported revenue of ₹30.5 Lakh for FY 2025, up 46% year on year.
Nanobrid specializes in a proprietary lipid-polymer hybrid nanotechnology platform that enhances drug delivery by addressing challenges like stability and efficacy. It enables the formulation and administration of difficult-to-deliver active ingredients across therapeutic areas, including topical, injectable, and oral routes. Based in India, the company focuses on superior drug entrapment and safety, targeting pharmaceutical applications to improve clinical outcomes and patient experiences.
NanoBrid offers Nanobrid Platform.
NanoBrid operates through Nanobrid Innovations Private Limited.
The legal entities of NanoBrid currently have 2 directors, including Mayank Bhailalbhai Bhanderi, Deepak Chitkara.